Cargando…

Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019

Detalles Bibliográficos
Autores principales:	Igbinosa, Irogue, Miller, Sarah, Bianco, Katherine, Nelson, Joanna, Kappagoda, Shanthi, Blackburn, Brian G., Grant, Philip, Subramanian, Aruna, Lyell, Deirdre J., El-Sayed, Yasser Y., Aziz, Natali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410790/ https://www.ncbi.nlm.nih.gov/pubmed/32771381 http://dx.doi.org/10.1016/j.ajog.2020.08.001

Ejemplares similares

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Anemia and Severe Maternal Morbidity
por: Igbinosa, Irogue I., et al.
Publicado: (2023)

Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series
por: Singh, Renu, et al.
Publicado: (2021)

Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020
por: Ferguson, Jessica, et al.
Publicado: (2020)

Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
por: Montastruc, François, et al.
Publicado: (2020)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020
por: Steinberg, Jecca R., et al.
Publicado: (2021)

Remdesivir in pregnant women with moderate to severe coronavirus disease 2019 (COVID-19): a retrospective cohort study
por: Arbabzadeh, Taraneh, et al.
Publicado: (2023)

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center
por: McCoy, Jennifer A., et al.
Publicado: (2020)

Comparison of rapid immunoassays for rupture of fetal membranes
por: Igbinosa, Irogue, et al.
Publicado: (2017)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
por: Yang, Chih-Jen, et al.
Publicado: (2021)

WITHDRAWN: Remdesivir investigational trials in coronavirus disease 2019: a critical reappraisal()()
por: Brouqui, P., et al.
Publicado: (2020)

Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021)

The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
por: Roshanshad, Amirhossein, et al.
Publicado: (2020)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support
por: Alibrahim, Rim S., et al.
Publicado: (2022)

Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
por: Touafchia, Anthony, et al.
Publicado: (2021)

Preeclampsia treatment in severe acute respiratory syndrome coronavirus 2
por: Joudi, Noor, et al.
Publicado: (2020)

Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
por: Kanai, Osamu, et al.
Publicado: (2021)

Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
por: Sarfraz, Azza, et al.
Publicado: (2021)

Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy
por: Dividis, Georgios P, et al.
Publicado: (2022)

Neglected tropical diseases: survey and geometry of randomised evidence
por: Kappagoda, Shanthi, et al.
Publicado: (2012)

Remdesivir in a pregnant patient with COVID-19 pneumonia
por: Dande, Ranadheer, et al.
Publicado: (2021)

Health disparities among pregnant women with sars-cov-2 infection at a university medical center in northern California
por: Igbinosa, I., et al.
Publicado: (2020)

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
por: Olender, Susan A, et al.
Publicado: (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
por: Wang, Manli, et al.
Publicado: (2020)

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021)

Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia
por: Singh, Vinita, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019
por: Ide, Satoshi, et al.
Publicado: (2021)

Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
por: Rüfenacht, Susanne, et al.
Publicado: (2022)

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
por: Cramer, Patrick, et al.
Publicado: (2021)

Coronavirus disease 2019 in pregnant and non-pregnant women: a retrospective study
por: Zha, Ying, et al.
Publicado: (2021)

Psychological impact of coronavirus disease 2019 in pregnant women
por: Saccone, Gabriele, et al.
Publicado: (2020)

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study
por: Chouchana, Laurent, et al.
Publicado: (2021)

Use of Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19) infection among Sudanese patients: a case series
por: Yousif, Maysoun, et al.
Publicado: (2022)

Evaluation of the effect of Remdesivir on some biomarkers in Iraqi patients with coronavirus 2019 (COVID-19): A cross-sectional study
por: Abdul Khaleq, Maysaa Ali
Publicado: (2023)

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
por: Jittamala, Podjanee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mh2q6qabttn0sf6smsi6cc7pp4